ÅǸ޴º
Á¦¸ñ | Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard | µî·ÏÀÏ | 20160325 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard
molecular testing is negative. ONCOTARGET 2016 March 16 |
Copyright ¨Ï chamc, All rights reserved.